Cogent Biosciences, Inc. (COGT)
NASDAQ · Healthcare
Cogent Biosciences, Inc. annual/quarterly shareholder equity history from 2017 to 2020. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cogent Biosciences, Inc. shareholder equity for the quarter ending December 31, 2020 were 234.7M, a 638.83% increase year-over-year.
- Cogent Biosciences, Inc. shareholder equity for 2020 were 234.7M, a 638.83% increase from 2019.
- Cogent Biosciences, Inc. shareholder equity for 2019 were 31.8M, a 47.27% decrease from 2018.
- Cogent Biosciences, Inc. shareholder equity for 2018 were 60.2M, a 223.31% decrease from 2017.
- Cogent Biosciences, Inc. shareholder equity for 2017 were -48.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cogent Biosciences, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2020 | $235 |
| 2019 | $32 |
| 2018 | $60 |
| 2017 | $-49 |
| Cogent Biosciences, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2020-12-31 | $235 |
| 2019-12-31 | $32 |
| 2018-12-31 | $60 |
| 2017-12-31 | $-49 |
Cogent Biosciences, Inc. Shareholder Equity — FAQ
Cogent Biosciences, Inc. (COGT) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COGT's shareholder equity history?
The chart and table above show Cogent Biosciences, Inc.'s shareholder equity by year and by quarter, including the growth rate.